Biogen Idec and the University of Edinburgh in Scotland agreed to a three-year partnership for the study of the cell processes linked to multiple sclerosis and motor neurone disease. The collaboration covers the identification of drug compounds for possible use as therapies for the neurodegenerative disorders.

Full Story:
PharmaTimes (U.K.)

Related Summaries